Pneumonia
507 results
1 - 100
Corticosteroids for pneumonia- Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community‐acquired pneumonia
- Oxygen therapy for pneumonia in adults
- Chest physiotherapy for pneumonia in children
- Vitamin A for non‐measles pneumonia in children
- Antibiotics for community‐acquired pneumonia in children
- Vitamin C supplementation for prevention and treatment of pneumonia
- Antibiotics for hospital‐acquired pneumonia in neonates and children
- Antibiotics for ventilator‐associated pneumonia
- Chest physiotherapy for pneumonia in adults
- Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia
- Vitamin C for preventing and treating pneumonia: Cochrane systematic review
- Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease
- Probiotics for preventing ventilator‐associated pneumonia
- Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease
- Antibiotics for treating community‐acquired pneumonia in people with sickle cell disease
- Oral antibiotics versus parenteral antibiotics for severe pneumonia in children
- Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months
- Surfactant for bacterial pneumonia in late preterm and term infants: Cochrane systematic review
- Oral care measures for preventing nursing home‐acquired pneumonia
- Antibiotics for community‐acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children
- Zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age
- Prophylaxis for Pneumocystis pneumonia (PCP) in non‐HIV immunocompromised patients
- Over‐the‐counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults
- Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection
- Empiric antibiotic coverage of atypical pathogens for community‐acquired pneumonia in hospitalized adults
- Oral hygiene care for critically ill patients to prevent ventilator‐associated pneumonia
- Short‐course versus prolonged‐course antibiotic therapy for hospital‐acquired pneumonia in critically ill adults
- Pneumococcal conjugate vaccines for preventing invasive pneumococcal disease and pneumonia in children aged up to five years
- Antibiotic therapy versus no antibiotic therapy for children aged 2 to 59 months with WHO‐defined non‐severe pneumonia and wheeze
- Granulocyte-Colony Stimulating Factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults: Cochrane systematic review
- Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator‐associated pneumonia
- Antibiotics for community-acquired pneumonia in adult outpatients: Cochrane systematic review
- Short‐course versus long‐course therapy of the same antibiotic for community‐acquired pneumonia in adolescent and adult outpatients
- Silver‐coated endotracheal tubes for prevention of ventilator‐associated pneumonia in critically ill patients
- Post‐pyloric versus gastric tube feeding for preventing pneumonia and improving nutritional outcomes in critically ill adults
- Pneumococcal conjugate vaccines for preventing vaccine‐type invasive pneumococcal disease and X‐ray defined pneumonia in children less than two years of age
- Short‐course versus long‐course intravenous therapy with the same antibiotic for severe community‐acquired pneumonia in children aged two months to 59 months
- Short‐course versus long‐course antibiotic therapy for non‐severe community‐acquired pneumonia in children aged 2 months to 59 months
- Semi‐recumbent position versus supine position for the prevention of ventilator‐associated pneumonia in adults requiring mechanical ventilation